Anzeige
Mehr »
Montag, 16.02.2026 - Börsentäglich über 12.000 News
FRIEDLANDS 10.000-JAHRE-SCHOCK: Der Kupfer-Engpass hat begonnen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
716 Leser
Artikel bewerten:
(2)

Transfection Technologies Market to Witness Exponential Growth by 2023 | Key Players Profiled: QIAGEN, Bio-Rad, Sigma Aldrich, Lonza, Promega, Roche, & Maxcyte: Radiant Insights, Inc.

SAN FRANCISCO, Aug. 13, 2019 /PRNewswire/ -- Global Transfection Technologies Market is expected to grow at a significant CAGR in the upcoming period as the scope and its applications are rising enormously across the globe. Transfection technology is used to introduce nucleic acids like RNA or DNA into cells. It helps to regulate gene therapy, protein metabolism, and mutation of cancer cells by affecting the nuclear genes.

The factors that are playing a major role in the growth of transfection technologies market are the rise in research and development sector, the rising investment by private manufacturers and by the government, and the growing occurrence of cancer. However, the high cost of instruments may restrain the overall market growth in the years to come. Market of Transfection technologies is segmented based on type, application, and region.

The siRNA delivery, gene delivery, protein delivery, and DNA delivery are the types that could be explored in transfection technologies market in the forecast period. The market may be categorized based on applications like protein production, therapeutic delivery, biomedical research, and others that could be explored in the forecast period.

Download PDF to know more details about "Global Transfection Technologies Market" Report 2023.

Transfection technologies market is segmented geographically into Americas (North America, South America), Europe (Eastern Europe, Western Europe), Asia Pacific (India, China, Japan, New Zealand, and Australia), Middle East (UAE, Saudi, and Qatar) and Africa (South Africa).

Globally, North America may account for the substantial share of transfection technologies market and is estimated to lead the overall market in the years to come. The reason behind the overall market growth could the growing occurrence of infectious diseases, the rising use of cell-based products, and the high demand for antibiotics. The United States and Canada are the major consumers of transfection technologies in this region.

Europe and the Asia Pacific are also estimated to have a positive influence on future growth. Europe is the second largest region with significant market share. However, Asia Pacific is estimated to grow at the highest CAGR in the forecast period. The developing countries like India and China are the major consumers of transfection technologies in this region.

The key players of transfection technologies market are Thermo Fisher Scientific, Agilent Technologies, QIAGEN, Bio-Rad Laboratories, Promega, and Lonza. These players are concentrating on inorganic growth to sustain themselves amidst fierce competition.

Access 105 page research report with TOC on "Global Transfection Technologies Market" available with Radiant Insights, Inc. @: https://www.radiantinsights.com/research/global-transfection-technologies-market

Market Segmentation:

  • Geographically, this report is segmented into several key Regions, with production, consumption, revenue (M USD), market share and growth rate of Transfection Technologies in these regions, from 2012 to 2023 (forecast), covering
    • North America (United States, Canada and Mexico)
    • Europe (Germany, France, UK, Russia and Italy)
    • Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
    • South America (Brazil, Argentina, Columbia)
    • Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
  • Global Transfection Technologies market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
    • Life Technologies
    • Sigma Aldrich
    • Lonza
    • Promega
    • Qiagen
    • Bio-Rad
    • Roche
    • Polyplus Transfection
    • Mirius Bio
    • Maxcyte
  • On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    • Reagent
    • Instrument
  • On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Transfection Technologies for each application, including
    • Therapeutic delivery
    • Bio-Medical research
    • Protein production

Browse reports of similar category available with Radiant Insights, Inc.:

  • Endoscopy Devices Market
  • Anesthesia Devices Market
  • Anesthesia Masks Market
  • Dental Veneers Market

About Radiant Insights, Inc.:

At Radiant Insights, we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions.

Contact:

Michelle Thoras.
Corporate Sales Specialist
Radiant Insights, Inc
Phone: +1-415-349-0054
Toll Free: 1-888-928-9744
Email: sales@radiantinsights.com
Web: https://www.radiantinsights.com

© 2019 PR Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.